OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 69 filers reported holding OCULAR THERAPEUTIX INC in Q4 2017. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,000 | +100.0% | 700 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 700 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 700 | -50.0% | 0.00% | – |
| Q4 2017 | $6,000 | +50.0% | 1,400 | +100.0% | 0.00% | – |
| Q3 2017 | $4,000 | -33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | -68.4% | 700 | -68.2% | 0.00% | -100.0% |
| Q4 2016 | $19,000 | 0.0% | 2,200 | -18.5% | 0.00% | 0.0% |
| Q3 2016 | $19,000 | +533.3% | 2,700 | +285.7% | 0.00% | – |
| Q2 2016 | $3,000 | -57.1% | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |